rs4977574
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000428597.7(CDKN2B-AS1):n.2698+1211A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.405 in 152,068 control chromosomes in the GnomAD database, including 13,949 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as risk factor (no stars).
Frequency
Genomes: 𝑓 0.40 ( 13949 hom., cov: 32)
Consequence
CDKN2B-AS1
ENST00000428597.7 intron
ENST00000428597.7 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0800
Publications
308 publications found
Genes affected
CDKN2B-AS1 (HGNC:34341): (CDKN2B antisense RNA 1) This gene is located within the CDKN2B-CDKN2A gene cluster at chromosome 9p21. The gene product is a functional RNA molecule that interacts with polycomb repressive complex-1 (PRC1) and -2 (PRC2), leading to epigenetic silencing of other genes in this cluster. This region is a significant genetic susceptibility locus for cardiovascular disease, and has also been linked to a number of other pathologies, including several cancers, intracranial aneurysm, type-2 diabetes, periodontitis, Alzheimer's disease, endometriosis, frailty in the elderly, and glaucoma. Multiple alternatively processed transcript variants have been detected, some of which may take the form of circular RNA molecules (PMID:21151960). [provided by RefSeq, May 2014]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.506 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CDKN2B-AS1 | NR_003529.4 | n.2698+1211A>G | intron_variant | Intron 14 of 18 | ENST00000428597.7 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CDKN2B-AS1 | ENST00000428597.7 | n.2698+1211A>G | intron_variant | Intron 14 of 18 | 1 | NR_003529.4 |
Frequencies
GnomAD3 genomes AF: 0.405 AC: 61532AN: 151950Hom.: 13962 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
61532
AN:
151950
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.405 AC: 61534AN: 152068Hom.: 13949 Cov.: 32 AF XY: 0.402 AC XY: 29893AN XY: 74348 show subpopulations
GnomAD4 genome
AF:
AC:
61534
AN:
152068
Hom.:
Cov.:
32
AF XY:
AC XY:
29893
AN XY:
74348
show subpopulations
African (AFR)
AF:
AC:
7563
AN:
41510
American (AMR)
AF:
AC:
6886
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
AC:
2159
AN:
3464
East Asian (EAS)
AF:
AC:
2505
AN:
5168
South Asian (SAS)
AF:
AC:
2517
AN:
4810
European-Finnish (FIN)
AF:
AC:
4585
AN:
10578
Middle Eastern (MID)
AF:
AC:
186
AN:
294
European-Non Finnish (NFE)
AF:
AC:
33689
AN:
67960
Other (OTH)
AF:
AC:
993
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1746
3492
5237
6983
8729
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
598
1196
1794
2392
2990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1705
AN:
3478
ClinVar
Significance: risk factor
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Three Vessel Coronary Disease Other:1
-
Department of Cardiology, Chinese Academy of Medical Sciences, Fuwai Hospital
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.